AFP Photographers Honoured at the 2024 POY Awards

Finnish deep tech startup Fiberwood Ltd has secured €3.1 million in funding from the EU LIFE Programme to reduce buildings' carbon footprints. The company will use the grant to scale up its sustainable insulation solutions made from wood industry side streams and accelerate its entry into broader European markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250616312925/en/By refining underutilised materials such as mechanical wo...

Epassi Group’s acquisition of VIP District (www.vipdistrict.com) marks a major milestone in Epassi’s pan-European growth strategy and follows Epassi’s recent acquisition of Zest in the UK, which expanded the Group’s UK footprint and enhanced its overall employee benefits software offering. With VIP District now part of the Epassi family, the Group significantly expands its footprint into Spain and Portugal, while strengthening its existing presence in Italy, Germany, and the Netherlands. Foun...

New research from Smoke Free Sweden reveals oral nicotine pouches are a game-changer in Sweden’s path to becoming the world’s first smoke-free nation – and are driving unprecedented success among women. The report, Power in a Pouch, launched today in Strasbourg, shows pouches have been a decisive catalyst in Sweden’s public health success – especially for women, who are quitting smoking faster and more effectively than ever. Since their introduction in 2016, tobacco-free pouches have: He...

PharmSight Research & Analytics today announces the opening of its European hub in Zug, Switzerland. Operating as PharmSight GmbH, this strategic expansion reinforces the company’s commitment to deliver data-driven insights for negotiation training, sales force optimization, and market access solutions in the heart of Europe’s pharmaceutical ecosystem. Leading PharmSight GmbH is Mr Gianclaudio Floria, recently appointed CEO with over 20 years of experience in commercial operations and str...

Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, announced today at the Paris Air Show that Tassili Travail Aérien (TTA) has signed a purchase agreement for two new Cessna SkyCourier aircraft, marking the first order of an aero-medical equipped SkyCourier and the first SkyCourier order in Africa. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250616699259/en/Textron Aviation and Tassili Travail Aérien celebrate first aero-...

In a rapidly evolving digital economy, telecommunications and financial services companies face mounting pressure to modernise, scale operations and unlock innovation—all while managing costs and navigating complex growth journeys. Today, CSG® (NASDAQ: CSGS) announced a new strategic collaboration agreement with Amazon Web Services (AWS) to fast-track cloud transformation across these industries. The initiative will come to life through advanced cloud-native technologies, cost optimisation and ...

Aqara, global leader and pioneer in IoT, unveils the new Smart Lock U200 Lite, offering effortless access control, enhanced security, and a modern keyless lifestyle to more European households, particularly those seeking budget-friendly solutions. Designed for DIY installation, the U200 Lite features a retrofit design compatible with most Euro mortise locks. It also supports Matter over Thread to ensure compatibility with a wide range of connected devices and seamless integration into users’ ex...

Toshiba Electronic Devices & Storage Corporation ("Toshiba") has launched four 650V silicon carbide (SiC) MOSFETs, equipped with its latest[1] 3rd generation SiC MOSFET chips and housed in a compact DFN8x8 package, suitable for industrial equipment, such as switched-mode power supplies and power conditioners for photovoltaic generators. Volume shipments of the four devices, “TW031V65C,” “TW054V65C,” “TW092V65C,” and “TW123V65C,” start today. This press release features multimedia. View the ...

Leading international medical research company, MEDSIR announced today the positive results of the TUXEDO-3 trial at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025. This phase II study funded by Daiichi Sankyo and Merck, known as MSD outside of the United States and Canada, evaluates the efficacy and safety of patritumab deruxtecan (HER3-DXd) in patients with active brain metastases and leptomeningeal disease, serious complications associated with advanced s...